Zoekresultaten - 7 results

Point Prevalence Study of Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute-Care Hospitals: Results of the ECDC PPS 2017

a beta-lactamase inhibitor (J01CR05, 7.7%). The most frequently reported diagnoses for medical antimicrobial treatment were pneumonia (22.2%) and urinary tract infections (11.2%). The reason for antimicrobial use ...

Surveillance of bloodstream infections in Belgian hospitals ('SEP')-Annual report 2017, Data up to and including 2016

pneumonia has increased. Since 2013, methicillin resistance in S. aureus has decreased, while resistance to third generation cephalosporins and carbapenems in K. pneumoniae has increased. Health Topics:  ...

Surveillance of bloodstream infections in Belgian hospitals ('SEP')-Annual report 2016, Data up to and including 2015

microorganisms isolated from HA- BSI were E. coli and S. aureus. Since 2000, the incidence of E. coli and K. pneumonia HA- BSI has increased. Since 2013, methicillin resistance in S. aureus has decreased, while ...

Surveillance of bloodstream infections in Belgian hospitals ('SEP')-Annual report 2014, Surveillance data 2000-2014

microorganisms involved in HA- BSI changed with an increase in the incidence of HA- BSI due to Gram-negative microorganisms (Escherichia coli, Klebsiella pneumoniae) and a decrease of HA- BSI due to ...

Surveillance septicemieën in Belgische ziekenhuizen- Jaarrapport 2013, gegevens 2000-2013

2000 to 2.0/10,000 pd in 2013. For Klebsiella pneumoniae it rose from 0.3 to 0.6/10,000 pd, respectively. The annual mean incidence density of BSI associated with a central line (CLABSI) was 2.2/10,000 ...

Surveillanceprogramma van septicemieën in ziekenhuizen in België- Gegevens 2000-2011

aeruginosae and Klebsiella pneumoniae remained stable. These incidence data are higher than those reported by the surveillances (hospitalwide) from other countries. The results highlight the importance of the ...

Surveillance van nosocomiale septicemieën in Belgische ziekenhuizen, Data 1992-2001

micro-organisms (19.9%), followed by E. Coli (14.2%), S. aureus (13.6%), Streptococcus sp. (6.4%, with 2.1% S. pneumoniae), Enterobacter sp. (5.9%), Enterococcus sp. (5.6%), Candida sp. (5.4%), Klebsiella sp. ...

QR code

QR code for this page URL